1 Pharmaceutical Low Borosilicate Glass Bottles Market Overview
1.1 Product Overview and Scope of Pharmaceutical Low Borosilicate Glass Bottles
1.2 Pharmaceutical Low Borosilicate Glass Bottles Segment by Type
1.2.1 Global Pharmaceutical Low Borosilicate Glass Bottles Market Value Comparison by Type (2023-2029)
1.2.2 Injection Bottle
1.2.3 Ampoule
1.2.4 Oral Bottle
1.2.5 Others
1.3 Pharmaceutical Low Borosilicate Glass Bottles Segment by Application
1.3.1 Global Pharmaceutical Low Borosilicate Glass Bottles Market Value by Application: (2023-2029)
1.3.2 Pharma
1.3.3 Vaccine
1.3.4 Others
1.4 Global Pharmaceutical Low Borosilicate Glass Bottles Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Low Borosilicate Glass Bottles Revenue 2018-2029
1.4.2 Global Pharmaceutical Low Borosilicate Glass Bottles Sales 2018-2029
1.4.3 Global Pharmaceutical Low Borosilicate Glass Bottles Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pharmaceutical Low Borosilicate Glass Bottles Market Competition by Manufacturers
2.1 Global Pharmaceutical Low Borosilicate Glass Bottles Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pharmaceutical Low Borosilicate Glass Bottles Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pharmaceutical Low Borosilicate Glass Bottles Average Price by Manufacturers (2018-2023)
2.4 Global Pharmaceutical Low Borosilicate Glass Bottles Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pharmaceutical Low Borosilicate Glass Bottles, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Low Borosilicate Glass Bottles, Product Type & Application
2.7 Pharmaceutical Low Borosilicate Glass Bottles Market Competitive Situation and Trends
2.7.1 Pharmaceutical Low Borosilicate Glass Bottles Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharmaceutical Low Borosilicate Glass Bottles Players Market Share by Revenue
2.7.3 Global Pharmaceutical Low Borosilicate Glass Bottles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Low Borosilicate Glass Bottles Retrospective Market Scenario by Region
3.1 Global Pharmaceutical Low Borosilicate Glass Bottles Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pharmaceutical Low Borosilicate Glass Bottles Global Pharmaceutical Low Borosilicate Glass Bottles Sales by Region: 2018-2029
3.2.1 Global Pharmaceutical Low Borosilicate Glass Bottles Sales by Region: 2018-2023
3.2.2 Global Pharmaceutical Low Borosilicate Glass Bottles Sales by Region: 2024-2029
3.3 Global Pharmaceutical Low Borosilicate Glass Bottles Global Pharmaceutical Low Borosilicate Glass Bottles Revenue by Region: 2018-2029
3.3.1 Global Pharmaceutical Low Borosilicate Glass Bottles Revenue by Region: 2018-2023
3.3.2 Global Pharmaceutical Low Borosilicate Glass Bottles Revenue by Region: 2024-2029
3.4 North America Pharmaceutical Low Borosilicate Glass Bottles Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Low Borosilicate Glass Bottles Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pharmaceutical Low Borosilicate Glass Bottles Sales by Country (2018-2029)
3.4.3 North America Pharmaceutical Low Borosilicate Glass Bottles Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Low Borosilicate Glass Bottles Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Low Borosilicate Glass Bottles Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pharmaceutical Low Borosilicate Glass Bottles Sales by Country (2018-2029)
3.5.3 Europe Pharmaceutical Low Borosilicate Glass Bottles Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Low Borosilicate Glass Bottles Market Facts & Figures by Country
3.6.1 Asia Pacific Pharmaceutical Low Borosilicate Glass Bottles Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pharmaceutical Low Borosilicate Glass Bottles Sales by Country (2018-2029)
3.6.3 Asia Pacific Pharmaceutical Low Borosilicate Glass Bottles Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pharmaceutical Low Borosilicate Glass Bottles Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Low Borosilicate Glass Bottles Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pharmaceutical Low Borosilicate Glass Bottles Sales by Country (2018-2029)
3.7.3 Latin America Pharmaceutical Low Borosilicate Glass Bottles Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pharmaceutical Low Borosilicate Glass Bottles Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Low Borosilicate Glass Bottles Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pharmaceutical Low Borosilicate Glass Bottles Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pharmaceutical Low Borosilicate Glass Bottles Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Low Borosilicate Glass Bottles Sales by Type (2018-2029)
4.1.1 Global Pharmaceutical Low Borosilicate Glass Bottles Sales by Type (2018-2023)
4.1.2 Global Pharmaceutical Low Borosilicate Glass Bottles Sales by Type (2024-2029)
4.1.3 Global Pharmaceutical Low Borosilicate Glass Bottles Sales Market Share by Type (2018-2029)
4.2 Global Pharmaceutical Low Borosilicate Glass Bottles Revenue by Type (2018-2029)
4.2.1 Global Pharmaceutical Low Borosilicate Glass Bottles Revenue by Type (2018-2023)
4.2.2 Global Pharmaceutical Low Borosilicate Glass Bottles Revenue by Type (2024-2029)
4.2.3 Global Pharmaceutical Low Borosilicate Glass Bottles Revenue Market Share by Type (2018-2029)
4.3 Global Pharmaceutical Low Borosilicate Glass Bottles Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pharmaceutical Low Borosilicate Glass Bottles Sales by Application (2018-2029)
5.1.1 Global Pharmaceutical Low Borosilicate Glass Bottles Sales by Application (2018-2023)
5.1.2 Global Pharmaceutical Low Borosilicate Glass Bottles Sales by Application (2024-2029)
5.1.3 Global Pharmaceutical Low Borosilicate Glass Bottles Sales Market Share by Application (2018-2029)
5.2 Global Pharmaceutical Low Borosilicate Glass Bottles Revenue by Application (2018-2029)
5.2.1 Global Pharmaceutical Low Borosilicate Glass Bottles Revenue by Application (2018-2023)
5.2.2 Global Pharmaceutical Low Borosilicate Glass Bottles Revenue by Application (2024-2029)
5.2.3 Global Pharmaceutical Low Borosilicate Glass Bottles Revenue Market Share by Application (2018-2029)
5.3 Global Pharmaceutical Low Borosilicate Glass Bottles Price by Application (2018-2029)
6 Key Companies Profiled
6.1 SCHOTT Pharma
6.1.1 SCHOTT Pharma Corporation Information
6.1.2 SCHOTT Pharma Description and Business Overview
6.1.3 SCHOTT Pharma Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.1.4 SCHOTT Pharma Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.1.5 SCHOTT Pharma Recent Developments/Updates
6.2 Gerresheimer AG
6.2.1 Gerresheimer AG Corporation Information
6.2.2 Gerresheimer AG Description and Business Overview
6.2.3 Gerresheimer AG Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Gerresheimer AG Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.2.5 Gerresheimer AG Recent Developments/Updates
6.3 SGD Pharma
6.3.1 SGD Pharma Corporation Information
6.3.2 SGD Pharma Description and Business Overview
6.3.3 SGD Pharma Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.3.4 SGD Pharma Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.3.5 SGD Pharma Recent Developments/Updates
6.4 Nipro PharmaPackaging
6.4.1 Nipro PharmaPackaging Corporation Information
6.4.2 Nipro PharmaPackaging Description and Business Overview
6.4.3 Nipro PharmaPackaging Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nipro PharmaPackaging Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.4.5 Nipro PharmaPackaging Recent Developments/Updates
6.5 Neubor Glass
6.5.1 Neubor Glass Corporation Information
6.5.2 Neubor Glass Description and Business Overview
6.5.3 Neubor Glass Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Neubor Glass Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.5.5 Neubor Glass Recent Developments/Updates
6.6 Shandong Pharmaceutical Glass
6.6.1 Shandong Pharmaceutical Glass Corporation Information
6.6.2 Shandong Pharmaceutical Glass Description and Business Overview
6.6.3 Shandong Pharmaceutical Glass Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Shandong Pharmaceutical Glass Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.6.5 Shandong Pharmaceutical Glass Recent Developments/Updates
6.7 Linuo Group
6.6.1 Linuo Group Corporation Information
6.6.2 Linuo Group Description and Business Overview
6.6.3 Linuo Group Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Linuo Group Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.7.5 Linuo Group Recent Developments/Updates
6.8 Cangzhou Four Stars Glass
6.8.1 Cangzhou Four Stars Glass Corporation Information
6.8.2 Cangzhou Four Stars Glass Description and Business Overview
6.8.3 Cangzhou Four Stars Glass Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cangzhou Four Stars Glass Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.8.5 Cangzhou Four Stars Glass Recent Developments/Updates
6.9 Zhengchuan Pharmaceutical Packaging
6.9.1 Zhengchuan Pharmaceutical Packaging Corporation Information
6.9.2 Zhengchuan Pharmaceutical Packaging Description and Business Overview
6.9.3 Zhengchuan Pharmaceutical Packaging Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Zhengchuan Pharmaceutical Packaging Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.9.5 Zhengchuan Pharmaceutical Packaging Recent Developments/Updates
6.10 Dezhou Jinghua Group
6.10.1 Dezhou Jinghua Group Corporation Information
6.10.2 Dezhou Jinghua Group Description and Business Overview
6.10.3 Dezhou Jinghua Group Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Dezhou Jinghua Group Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.10.5 Dezhou Jinghua Group Recent Developments/Updates
6.11 Trumph Junheng
6.11.1 Trumph Junheng Corporation Information
6.11.2 Trumph Junheng Pharmaceutical Low Borosilicate Glass Bottles Description and Business Overview
6.11.3 Trumph Junheng Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Trumph Junheng Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.11.5 Trumph Junheng Recent Developments/Updates
6.12 Kibing Group
6.12.1 Kibing Group Corporation Information
6.12.2 Kibing Group Pharmaceutical Low Borosilicate Glass Bottles Description and Business Overview
6.12.3 Kibing Group Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Kibing Group Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.12.5 Kibing Group Recent Developments/Updates
6.13 Jiangsu Chaohua Glass Products
6.13.1 Jiangsu Chaohua Glass Products Corporation Information
6.13.2 Jiangsu Chaohua Glass Products Pharmaceutical Low Borosilicate Glass Bottles Description and Business Overview
6.13.3 Jiangsu Chaohua Glass Products Pharmaceutical Low Borosilicate Glass Bottles Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jiangsu Chaohua Glass Products Pharmaceutical Low Borosilicate Glass Bottles Product Portfolio
6.13.5 Jiangsu Chaohua Glass Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Low Borosilicate Glass Bottles Industry Chain Analysis
7.2 Pharmaceutical Low Borosilicate Glass Bottles Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Low Borosilicate Glass Bottles Production Mode & Process
7.4 Pharmaceutical Low Borosilicate Glass Bottles Sales and Marketing
7.4.1 Pharmaceutical Low Borosilicate Glass Bottles Sales Channels
7.4.2 Pharmaceutical Low Borosilicate Glass Bottles Distributors
7.5 Pharmaceutical Low Borosilicate Glass Bottles Customers
8 Pharmaceutical Low Borosilicate Glass Bottles Market Dynamics
8.1 Pharmaceutical Low Borosilicate Glass Bottles Industry Trends
8.2 Pharmaceutical Low Borosilicate Glass Bottles Market Drivers
8.3 Pharmaceutical Low Borosilicate Glass Bottles Market Challenges
8.4 Pharmaceutical Low Borosilicate Glass Bottles Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
| ※参考情報 医薬品用低ホウケイ酸ガラスボトルは、主に医薬品の包装に使用されるガラス容器で、その特性により安全性と効果を確保するために設計されています。このガラスボトルは、特に化学的安定性や耐薬品性が求められる医薬品の貯蔵や輸送に適しており、多くの医療現場や製薬業界で重要な役割を果たしています。 低ホウケイ酸ガラスは、その名の通りホウケイ酸の含有量が低く、一般的にバリウム、カリウム、ナトリウムといった他の成分が多く含まれています。このような性質により、低ホウケイ酸ガラスは非常にクリアな透明度を持ち、視認性が高いため中身の確認が容易です。また、熱的特性も優れており、急激な温度変化に対する耐性が向上しています。これにより、煮沸滅菌やオートクレーブ処理などの高温処理にも耐えることができるため、医薬品の無菌状態を維持することが可能です。 低ホウケイ酸ガラスボトルの特徴として、まず第一に化学的な安定性が挙げられます。これは、ボトル内の医薬品が化学反応を起こしにくいことを示しており、特に酸性やアルカリ性の医薬品でも安心して使用できます。さらに、軽量であるため、輸送時の負担を軽減し、持ち運びが容易です。耐酸性や耐アルカリ性も高く、さまざまな薬剤に対して優れた耐久性を持っています。 種類に関しては、医薬品用低ホウケイ酸ガラスボトルは、その形状やサイズ、容量に応じて多様な形式があります。例えば、注射用のガラスボトルやドロッパー付きのボトル、さらにはピペットボトルなど、用途に応じて設計されています。ボトルの口径やキャップの種類もさまざまで、通常はラミネートやゴム栓を使用し、密閉性を高めています。また、無菌状態を保つために特別な製造プロセスが導入されており、清浄度の高い環境で作られています。 用途については、医薬品だけでなく、化粧品や食品など広範な分野にわたって使用されています。特に、インフュージョン、・点滴、あるいはワクチンなどの生命に直接関わる製品には、品質が特に強く求められます。また、低ホウケイ酸ガラスは、生物学的試験や研究目的でも使用されることが多く、実験室での試薬の保存や分析の際にもその特性を活かせます。 関連技術について言及すると、現在では、ガラスの製造技術や表面処理技術が進化し続けています。例えば、耐薬品性をさらに高めるためのコーティング技術が開発されており、ガラス表面に特殊な材料を追加することで、劣化を防ぐことができます。また、ボトル内部にシリコンコーティングを施すことで、薬剤とガラスの相互作用を抑える技術も存在します。これにより、ボトルからの成分溶出のリスクが低減し、医薬品の品質保持が一層進むことになります。 さらに、医薬品の包装においては、トレーサビリティや安全性のためのラベリング技術も重要です。QRコードやバーコードを使用することで、製品の情報を追跡することが可能となり、万が一のリコール時に迅速に対応できる体制が整いつつあります。このように、低ホウケイ酸ガラスボトルは、医薬品の製造から流通、使用に至る全過程での品質管理において重要な役割を果たしています。 今後も、医薬品業界における品質管理の基準が厳格化する中で、低ホウケイ酸ガラスボトルの需要はさらに高まると予想されます。製薬会社は、さらに新しい技術を取り入れながら、効率的で安全な包装材料の開発に努めることで、患者に対する信頼性の高い医療サービスを提供することが期待されます。このような取り組みを通じて、低ホウケイ酸ガラスボトルは、医薬品の信頼性を支える重要な素材として位置付けられ続けることでしょう。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
